drugset
drugset / Trial / NCT05826353

A Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Simultaneous Cataract Surgery and Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

NCT05826353 ↗

Phase 3 Completed 110 enrolled Kowa Research Institute, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A study to assess the safety and efficacy of K-321 in participants with FECD after simultaneous cataract surgery and descemetorhexis.

Timeline

Start
2023-05-11
Primary completion
2025-01-17
Completion
2025-10-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Ripasudil Small molecule — Other

Indications

Fuchs' endothelial dystrophy